Related Experiment Video

Updated: Aug 20, 2026

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
06:36

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds

Published on: September 8, 2021

Pomegranate extract inhibits Staphylococcus aureus growth and subsequent enterotoxin production

L C Braga1, J W Shupp, C Cummings

  • 1Departamento de Biologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Journal of Ethnopharmacology
|December 14, 2004
PubMed

Insights

Pomegranate extract shows antibacterial properties against Staphylococcus aureus. It delays growth at low concentrations, inhibits growth at high concentrations, and notably reduces the production of Staphylococcal enterotoxin A.

Area of Science:

  • Phytotherapy
  • Microbiology
  • Food Safety

Background:

  • Pomegranate (Punica granatum L.) is a traditional phytotherapeutic agent in Brazil.
  • Staphylococcus aureus is a pathogen known for producing enterotoxins that cause foodborne illnesses.
  • Understanding natural product efficacy against bacterial pathogens and their toxins is crucial for public health.

Purpose of the Study:

  • To investigate the antibacterial activity of pomegranate extract against Staphylococcus aureus FRI 722.
  • To assess the impact of pomegranate extract on Staphylococcus aureus enterotoxin production.

Main Methods:

  • Bacterial susceptibility testing using the tube dilution method.
  • Enterotoxin production assessment via membrane-over-agar (MOA) plates.

Main Results:

  • Pomegranate extract at 0.01% (v/v) delayed bacterial growth.
  • A concentration of 1% (v/v) pomegranate extract completely inhibited bacterial growth.
  • Notably, 0.05% (v/v) pomegranate extract inhibited the production of Staphylococcal enterotoxin A.

Conclusions:

  • Pomegranate extracts possess significant antibacterial activity against Staphylococcus aureus.
  • Pomegranate extract demonstrates potential as a therapeutic agent by inhibiting both bacterial growth and enterotoxin production.
  • These findings support the use of pomegranate in preventing foodborne illnesses caused by Staphylococcus aureus.

More Related Videos

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes12:27

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

Published on: January 3, 2020

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...